Zimmer Biomet Logo
US98956P1021

Zimmer Biomet

Ins Portfolio
Über 2000 Dividenden-Werte in einem kostengünstigen ETF. Jetzt entdecken
Anzeige

Kurse werden geladen...

 Anzeige

Prognose

Das durchschnittliche Kursziel der Analysten beträgt +102,14(+20,14%). Der Median liegt bei +102,14(+20,14%).

Kaufen
  19
Halten
  15
Verkaufen
  2

Scoring-Modelle

Dividenden-Strategie7 / 15
HGI-Strategie7 / 18
Levermann-Strategie-2 / 13
Powered byaktien.guide

News

  • Foto von These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results

    These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results

    Zimmer Biomet Holdings, Inc ZBH reported better-than-expected earnings for the first quarter on Monday.» Mehr auf benzinga.com

  • Foto von S&P 500 INDEX (SPX) Live: The Markets Turn Cautious in Data-Filled Week

    S&P 500 INDEX (SPX) Live: The Markets Turn Cautious in Data-Filled Week

    Live Updates Live Coverage Has Ended Markets Pivot to Ford Earnings 4:03 pm by Gerelyn Terzo The markets failed to turn around, ending the trading session lower across the board and ending a multi-session winning streak. Stocks are awaiting further details on trade deals, which the White House has revealed could come as soon as this week, which would not be soon enough for the markets. Ford (NYSE: F) stock fell just over 1% on the day ahead of the automaker’s quarterly results after the closing bell today. When fellow automaker General Motors (NYSE: GM) reported its quarterly results last month, the company withdrew its profit guidance due to tariff uncertainty. Here’s how the major indices finished the trading day: Dow Jones Industrial Average: Down 69.52 (-0.17%) Nasdaq Composite: Down 132.40 (-0.74%) S&P 500: Down 36.79 (-0.66%) Economic Uncertainty 12:32 pm by Gerelyn Terzo U.S. Treasury Secretary Scott Bessent is making the rounds, speaking to global investors today about President Trump’s economic plan. He pointed to a three-pronged approach, including tariffs, tax cuts and deregulation. Bessent’s remarks failed to provide any greater clarity on the status of tariff negotiations with key U.S. trade partners, leaving the markets at a standstill. The three major stock market averages remain mixed, with the Dow Jones Industrial Average moving higher while the S&P 500 and Nasdaq Composite remain lower. Winners and Losers 10:43 am by Gerelyn Terzo Airline stock Delta (NYSE: DAL) is gaining 3% on the day, while United Airlines (Nasdaq: UAL) is tacking on 2.7%. EQT (NYSE: EQT) is advancing by 2.9% on the day on the heels of a dividend announcement. Ralph Lauren (NYSE: RL) is up 2.8%. Tyson Foods (NYSE: TSN) is losing 9.6% today on a quarterly revenue miss. Zimmer Biomet (NYSE: ZBH) is also down 9%. In what is proving to be a volatile session on Wall Street, the markets have come off their lows of the session. The markets are coming off the heels of a nine-day winning streak and have come out of the gate with plenty of headlines to process, chief among which has been the announced retirement of Berkshire Hathaway (NYSE: BRK-B) CEO Warren Buffett. Wall Street firm TD Cowen has issued a report suggesting that price increases from tariffs will be reflected in May’s inflation data. The Federal Reserve gathers this week to determine the near-term outlook on interest rates while the markets will also be paying close attention to the tone in comments from Chairman Jerome Powell. First-quarter earnings continues to unfold as names like Palantir Technologies (Nasdaq: PLTR), Ford Motor (NYSE: F) and Diamondback Energy (Nasdaq: FANG) take the spotlight. Mag Seven stocks are a mixed bag as shares of Apple (Nasdaq: AAPL) extend their losses with a 2% decline today. Sectors of the economy were originally all lower but industrials and telecom stocks have since made their way into the green. Netflix (Nasdaq: NFLX) shares are lower after President Trump tossed in fresh tariffs on foreign-made films. Here’s a look at the performance as of morning trading: Dow Jones Industrial Average: Down 50.53 (-0.12%) Nasdaq Composite: Down 133.34 (-0.74%) S&P 500: Down 32.82 (-0.58%) Market Movers Berkshire Hathaway (NYSE: BRK-B) is down 6% but maintains a $1.1 trillion market cap as Buffett prepares to pass the reins to his successor Greg Abel at the end of the year. Footwear stock Skechers (NYSE: SKX) has decided to leave the publicly traded markets behind and has accepted a private equity takeover by 3G Capital for $63 per share, sending the stock higher by 25% percentage today. Jefferies maintains a “hold” rating on Tesla (Nasdaq: TSLA), suggesting the valuation has already given the stock the benefit of the doubt in areas like tech innovation and scalability. Mizuho analysts are bullish on Bloom Energy (NYSE: BE), lifting shares to an “outperform” rating from “neutral” on an attractive risk/reward profile and sending the stock 3.5% higher today. The post S&P 500 INDEX (SPX) Live: The Markets Turn Cautious in Data-Filled Week appeared first on 24/7 Wall St..» Mehr auf 247wallst.com

  • Foto von Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds

    Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds

    Zimmer Biomet's stock dropped nearly 10% on the back of soft Q1 results. Despite structural tailwinds, Zimmer Biomet's business is struggling in the face of high interest rates, trade tensions and competition. Zimmer Biomet's cash flows appear set to be particularly hard hit by tariffs, meaning the company's share price is likely to remain depressed until this is resolved.» Mehr auf seekingalpha.com

Dividenden

Alle Kennzahlen
In 2025 hat Zimmer Biomet bereits +0,44 Dividende ausgeschüttet. Die letzte Dividende wurde im April gezahlt.

Unternehmenszahlen

Im letzten Quartal hatte Zimmer Biomet einen Umsatz von +1,76 Mrd und ein Nettoeinkommen von 0,00
(EUR)März 2025
YOY
Umsatz+1,76 Mrd0,81%
Bruttoeinkommen+1,12 Mrd3,08%
Nettoeinkommen0,00100,00%
EBITDA0,00100,00%

Fundamentaldaten

MetrikWert
Marktkapitalisierung
+16,49 Mrd
Anzahl Aktien
197,84 Mio
52 Wochen-Hoch/Tief
+108,58 - +79,87
Dividendenrendite
+1,04%
Dividenden TTM
+0,89
Beta
0,78
KGV (PE Ratio)
+26,05
KGWV (PEG Ratio)
1,37
KBV (PB Ratio)
+1,37
KUV (PS Ratio)
+2,41

Unternehmensprofil

Zimmer Biomet Holdings, Inc. ist zusammen mit seinen Tochtergesellschaften im Bereich der muskuloskelettalen Gesundheitsfürsorge in Nord- und Südamerika, Europa, dem Nahen Osten, Afrika und im asiatisch-pazifischen Raum tätig. Das Unternehmen entwickelt, produziert und vertreibt orthopädische Rekonstruktionsprodukte wie Knie- und Hüftprothesen; S.E.T.-Produkte, einschließlich Sportmedizin, Biologika, Fuß- und Knöchelprothesen, Extremitäten und Traumaprodukte; Wirbelsäulenprodukte, die medizinische Geräte und chirurgische Instrumente umfassen; und Produkte zur Gesichts- und Schädelrekonstruktion sowie Produkte, die die Knochen des Brustkorbs fixieren und stabilisieren, um die Heilung oder den Wiederaufbau nach einer offenen Herzoperation, einem Trauma oder bei Deformationen des Brustkorbs zu erleichtern. Das Unternehmen bietet auch zahnmedizinische Produkte an, darunter rekonstruktive Zahnimplantate, zahnprothetische und regenerative Produkte sowie Roboter-, chirurgische und Knochenzementprodukte. Die Produkte und Lösungen des Unternehmens werden zur Behandlung von Patienten eingesetzt, die an Erkrankungen oder Verletzungen von Knochen, Gelenken oder stützendem Weichgewebe leiden. Das Unternehmen beliefert orthopädische Chirurgen, Neurochirurgen, Kieferchirurgen, Zahnärzte, Krankenhäuser, Vertriebshändler, Händler im Gesundheitswesen und andere Spezialisten sowie Vertreter, Einkaufsorganisationen im Gesundheitswesen oder Einkaufsgemeinschaften. Das Unternehmen war früher als Zimmer Holdings, Inc. bekannt und änderte im Juni 2015 seinen Namen in Zimmer Biomet Holdings, Inc. Zimmer Biomet Holdings, Inc. wurde 1927 gegründet und hat seinen Hauptsitz in Warsaw, Indiana.

Name
Zimmer Biomet
CEO
Ivan Tornos
SitzWarsaw, in
USA
Website
Industrie
Gesundheitswesen: Ausstattung und Produkte
Börsengang
Mitarbeiter17.000

Ticker Symbole

BörseSymbol
NYSE
ZBH
SIX
ZBH.SW
Frankfurt
ZIM.F
Düsseldorf
ZIM.DU
London
0QQD.L
München
ZIM.MU
Wien
ZBH.VI
Milan
1ZBH.MI

Assets entdecken

Shareholder von Zimmer Biomet investieren auch in folgende Assets

🍪

Parqet nutzt Cookies.Erfahre Mehr